12:00 AM
Sep 03, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice lethally infected with H1N1 influenza virus, a FluCide candidate led to a 1.3 log reduction in viral load when given once daily orally or every 2 days by IV injection vs. untreated controls. Another FluCide candidate led to a 1.23 log reduction in...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >